Jiangsu Recbio Technology Co., Ltd. (HKG:2179)
Hong Kong · Delayed Price · Currency is HKD 4.710
-0.100 (-2.08%)
Jun 18, 2026, 10:14 AM HKT
Jiangsu Recbio Technology Market Cap
Jiangsu Recbio Technology has a market cap or net worth of 2.97 billion as of June 17, 2026. Its market cap has decreased by -28.56% in one year.
Market Cap
2.97B
Enterprise Value
3.28B
Revenue
14.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
4.71
Market Cap Chart
Since March 31, 2022, Jiangsu Recbio Technology's market cap has decreased from 12.10B to 2.97B, a decrease of -75.48%. That is a compound annual growth rate of -28.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 17, 2026 | 2.97B | 20.25% |
| Dec 31, 2025 | 2.47B | -45.80% |
| Dec 31, 2024 | 4.55B | -12.74% |
| Dec 29, 2023 | 5.22B | -56.10% |
| Dec 30, 2022 | 11.88B | -1.79% |
| Mar 31, 2022 | 12.10B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Mirxes Holding Company | 3.66B |
| Jacobio Pharmaceuticals Group | 3.52B |
| Medtide | 3.38B |
| Qyuns Therapeutics | 3.37B |
| Shandong Boan Biotechnology | 3.04B |
| PegBio | 2.76B |
| BioDlink International Company | 2.74B |
| TYK Medicines | 2.65B |